-
公开(公告)号:US20240050366A1
公开(公告)日:2024-02-15
申请号:US18258861
申请日:2021-10-21
申请人: SOLYPLUS GMBH , LEOPOLD GMBH
IPC分类号: A61K9/68 , A61K31/722 , C07K16/10 , A61K9/00 , A61K47/36 , G01N33/569
CPC分类号: A61K9/0058 , A61K31/722 , C07K16/1003 , A61K9/006 , A61K47/36 , G01N33/56983 , G01N2333/165
摘要: Compounds and compositions, their use and methods using the compounds and compositions for preventing an infection, e.g. an infection by a virus or bacterium, or treating an infection, e.g. a virus or bacterial infection, or treating a disease caused by an infection, e.g. a virus or bacterial infection, and a method of increasing the binding of virus neutralizing antibodies, an in vitro method of detecting virus-specific antibodies in a sample obtained from a subject, a compound for use in a method of detecting of virus-specific antibodies in a subject, and a kit for the detection of virus-specific antibodies.
-
公开(公告)号:US11248094B2
公开(公告)日:2022-02-15
申请号:US16753500
申请日:2018-10-09
申请人: SolyPlus GmbH
摘要: The present invention relates to methods of providing biocompatible/biodegradable hydrogels obtained by crosslinking of biopolymers (for example polysaccharides or proteins) in the semi-solid (modelling-clay like) state at water content below 70% by weight. The resulting materials can be applied in medicine, pharmacy and/or in cosmetics.
-
公开(公告)号:US20230346824A1
公开(公告)日:2023-11-02
申请号:US17918679
申请日:2021-04-14
申请人: SolyPlus GmbH , Leopold GmbH
IPC分类号: A23L29/275 , A23G4/10 , A23L2/52 , A61K31/722 , A61K31/7004 , A61K31/522 , A61K9/68 , A61P31/14
CPC分类号: A61K31/722 , A23G4/10 , A23L2/52 , A23L29/275 , A61K9/0058 , A61K31/522 , A61K31/7004 , A61P31/14
摘要: A composition for use in preventing an infection, or treating an infection, or treating a disease caused by an infection, the composition including a compound selected from the group of chitosan or a salt thereof, galactose, mannose, caffeine, and any combination thereof.
-
-